Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Stella Pharma Corporation

4888
Current price
509.00 JPY +12.05 JPY (+2.41%)
Last closed 501.00 JPY
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Tokyo Stock Exchange
Capitalization 16 944 372 869 JPY
Yield for 12 month +83.75 %
1Y
3Y
5Y
10Y
15Y
4888
21.11.2021 - 28.11.2021

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan. Address: ORIX Kouraibashi Building, Osaka, Japan, 541-0043

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+270 504 904 JPY

Last Year

+229 928 852 JPY

Current Quarter

+61 829 692 JPY

Last Quarter

+69 558 720 JPY

Current Year

+218 115 448 JPY

Last Year

+207 722 627 JPY

Current Quarter

+43 193 882 JPY

Last Quarter

+54 822 487 JPY

Key Figures 4888

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -694 603 497 JPY
Operating Margin TTM -94.44 %
PE Ratio
Return On Assets TTM -9.72 %
PEG Ratio
Return On Equity TTM -24.56 %
Wall Street Target Price
Revenue TTM 286 072 218 JPY
Book Value 91.30 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17.40 %
Dividend Yield
Gross Profit TTM 85 319 784 JPY
Earnings per share -23.01 JPY
Diluted Eps TTM -23.01 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -254.74 %

Dividend Analytics 4888

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History 4888

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 4888

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 49.67
Price Sales TTM 59.83
Enterprise Value EBITDA -15.26
Price Book MRQ 5.54

Financials 4888

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4888

For 52 weeks

229.86 JPY 604.26 JPY
50 Day MA 512.14 JPY
Shares Short Prior Month
200 Day MA 395.05 JPY
Short Ratio
Shares Short
Short Percent